These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 34248855)
1. Challenges in Cytology Specimens With Hürthle Cells. Thodou E; Canberk S; Schmitt F Front Endocrinol (Lausanne); 2021; 12():701877. PubMed ID: 34248855 [TBL] [Abstract][Full Text] [Related]
2. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates. Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786 [No Abstract] [Full Text] [Related]
3. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology. Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935 [TBL] [Abstract][Full Text] [Related]
4. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries. Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897 [TBL] [Abstract][Full Text] [Related]
5. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India. Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624 [TBL] [Abstract][Full Text] [Related]
6. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study. Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003 [TBL] [Abstract][Full Text] [Related]
7. Thyroid nodules with Hürthle cells: the malignancy risk in relation to the FNA outcome category. Słowińska-Klencka D; Wysocka-Konieczna K; Woźniak-Oseła E; Sporny S; Popowicz B; Sopiński J; Kaczka K; Kuzdak K; Pomorski L; Klencki M J Endocrinol Invest; 2019 Nov; 42(11):1319-1327. PubMed ID: 31077094 [TBL] [Abstract][Full Text] [Related]
8. A case series of thyroid fine needle aspiration biopsies diagnosed as follicular neoplasm with oncocytic features. Chen CV; Krishnan V; Greenland NY Diagn Cytopathol; 2024 Oct; 52(10):553-557. PubMed ID: 38581413 [TBL] [Abstract][Full Text] [Related]
9. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Montone KT; Baloch ZW; LiVolsi VA Arch Pathol Lab Med; 2008 Aug; 132(8):1241-50. PubMed ID: 18684023 [TBL] [Abstract][Full Text] [Related]
10. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis. Elliott DD; Pitman MB; Bloom L; Faquin WC Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320 [TBL] [Abstract][Full Text] [Related]
11. Hürthle cells in fine-needle aspirates of the thyroid: a review of their diagnostic criteria and significance. Auger M Cancer Cytopathol; 2014 Apr; 122(4):241-9. PubMed ID: 24436122 [TBL] [Abstract][Full Text] [Related]
12. Hürthle cell lesions of the thyroid: Progress made and challenges remaining. Wong KS; Angell TE; Barletta JA; Krane JF Cancer Cytopathol; 2021 May; 129(5):347-362. PubMed ID: 33108684 [TBL] [Abstract][Full Text] [Related]
13. Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease. Alaedeen DI; Khiyami A; McHenry CR Surgery; 2005 Oct; 138(4):650-6; discussion 656-7. PubMed ID: 16269293 [TBL] [Abstract][Full Text] [Related]
14. Hurthle cells in fine needle aspiration cytology of the thyroid: a potential diagnostic dilemma? Wong YP; Md Isa N; Md Zin RR; Noor Akmal S Malays J Pathol; 2015 Apr; 37(1):49-52. PubMed ID: 25890614 [TBL] [Abstract][Full Text] [Related]
15. Predictors of malignancy in patients with a thyroid nodule that contains Hürthle cells. Turanli S; Pirhan Y; Ozcelik CK; Cetin A Otolaryngol Head Neck Surg; 2011 Apr; 144(4):514-7. PubMed ID: 21493226 [TBL] [Abstract][Full Text] [Related]
16. Interobserver variability with the interpretation of thyroid FNA specimens showing predominantly Hürthle cells. Stelow EB; Woon C; Atkins KA; Bardales RH; Cathro HP; Frierson HF; Stanley MW; Savik K; Pambuccian SE Am J Clin Pathol; 2006 Oct; 126(4):580-3. PubMed ID: 16938664 [TBL] [Abstract][Full Text] [Related]
17. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact. Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE; Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572 [TBL] [Abstract][Full Text] [Related]
18. Fine-needle aspiration cytology of thyroid nodules with Hürthle cells: cytomorphologic predictors for neoplasms, improving diagnostic accuracy and overcoming pitfalls. Kasper KA; Stewart J; Das K Acta Cytol; 2014; 58(2):145-52. PubMed ID: 24525356 [TBL] [Abstract][Full Text] [Related]
19. Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience. Xavier-Júnior JCC; Abrantkoski Borges F; Pizzello Zogheib RJ; Camilo-Júnior DJ Acta Cytol; 2021; 65(1):22-26. PubMed ID: 32877898 [TBL] [Abstract][Full Text] [Related]
20. Unraveling Hürthle cell lesions of the thyroid using molecular findings. Wong KS Cancer Cytopathol; 2022 Jun; 130(6):405-406. PubMed ID: 35285577 [No Abstract] [Full Text] [Related] [Next] [New Search]